MARLINE TOUSSAINT: Open Payments
NPI 1659842318 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 54 payments from 12 companies in 2025. Trend: 2023 $779 · 2024 $1,466 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $278 |
| Otsuka America Pharmaceutical, Inc. | 15 | $271 |
| Supernus Pharmaceuticals, Inc. | 5 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Tris Pharma Inc | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: VRAYLAR, REXULTI, Qelbree, COBENFY, INGREZZA, Jornay PM, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
